INSIGHT KETAMINE CLINIC, RESOURCES
News
- CNN
Ketamine offers lifeline for people with severe depression, suicidal thoughts - Rolling Stone
Could Party Drug Ketamine Be a Treatment for Depression? Special K, a Vietnam-era anesthetic favored by ravers looking for an intense high, is being given another chance – this time as legitimate medication. - The New York Times
Can We Stop Suicides? It’s been way too long since there was a new class of drugs to treat depression. Ketamine might be the solution. - The Verge
The FDA approved a new ketamine depression drug — here’s what’s next. - Time
New hope for depression. - Vox
I tried ketamine to treat my depression. Within a day, I felt relief. How the veterinary anesthetic and recreational drug saved me from suicidal thoughts. - Wired
Ketamine stirs up hope—and controversy—as a depression drug.
Patient Resource Links
- Bloomberg Business Week
Is ketamine the best hope for curing major depression? - Ketamine Advocacy Network
A Non-Profit organization helping educate patients and find help using ketamine therapy. - MEDPAGE TODAY
IV Ketamine Rapidly Effective in PTSD - Medscape
Ketamine: New Potential as Rapid PTSD Treatment - Nautilus
A Vaccine for Depression: Ketamine’s remarkable effect bolsters a new theory of mental illness. - Science Daily
Low Doses Of A Common Intravenous Anesthetic May Relieve Debilitating Pain Syndrome - Scientific American
Rave Drug "Special K" Holds Promise for Treating Depression Fast - The Detroit News
Ketamine gains favor to treat longterm pain, depression. - Web MD
Ketamine: The Future of Depression Treatment
Podcast
- Dr. Lowan Stewart: Ketamine and Ketamine assisted psychotherapy
Dr. Lowan Stewart is a Specialist Emergency Physician and cofounder of Santa Fe Ketamine in New Mexico, Axonklinikken Norway and the first unit of ketamine treatment in Scandinavia at Sykehuset Østfold. Dr. Stewart is also a part of the psychedelic research group at the Department of Psychology at UiO. - Ketamine for the treatment of substance use disorders – Dr. Lowan H Stewart at NPSC 2022
Dr. Lowan H Stewart at Nordic Psychedelic Science Conference 2022. - Lowan H. Stewart
Lowan H. Stewart shares his research results and personal professional experience with therapeutic use of psychedelics in treating depression, PTSD, anxiety, addiction, pain, OCD etc.
Provider Resource Links
- (2021) Ketamine as a Treatment for Anorexia Nervosa A Narrative Review
Anorexia nervosa (AN) is a highly complex disorder to treat, especially in severe and enduring cases. - A comparative study of ketamine vs electroconvulsive therapy in the management of major depressive disorder
The aim was to investigate the efficacy of ketamine vs electroconvulsive therapy (ECT) in hospitalized patients suffering from treatment‑resistant major depressive disorder (MDD). - A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
Posttraumatic stress disorder (PTSD) is a chronic and disabling disorder, for which available pharmacotherapies have limited efficacy. - Biological Psychiatry
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression. - Biological Psychiatry
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression. - CNS Neuroscience and Therapeutics
Ketamine in pain management. - Comparison of Rapid Antidepressant and Antisuicidal Effects of Intramuscular Ketamine, Oral Ketamine, and Electroconvulsive Therapy in Patients With Major Depressive Disorder
This study was devised to compare the antidepressant and antisuicidal effects of oral and intramuscular (IM) ketamine versus electroconvulsive therapy (ECT). - Current Physical Medicine and Rehabilitation Reports
The use of ketamine in neuropathic pain. - Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
To assess the efficacy, safety, and dose-response of intranasal esketamine hydrochloride in patients with treatment-resistant depression (TRD). - Efficacy of Ketamine in the Treatment of Substance Use Disorders- A Systematic Review
Despite advances in behavioral and pharmacotherapy interventions, substance use disorders (SUDs) are frequently refractory to treatment. - Emerging concepts on the use of ketamine for chronic pain
The use of ketamine infusions for chronic pain has surged, with utilization exceeding the proliferation of knowledge. - Evidence-Based Mental Health BMJ
Ketamine for treatment-resistant depression: recent developments and clinical applications. - International Anesthesia Research Society
Ketamine in Chronic Pain Management: An Evidence-Based Review - JAMA Psychiatry
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. - JAMA Psychiatry
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder A Randomized Clinical Trial. - Ketamine rapidly relieves acute suicidal ideation in cancer patients: A randomized controlled clinical trial
This study was designed to examine the rapid antidepressant effects of single dose ketamine on suicidal ideation and overall depression level in patients with newly-diagnosed cancer. - New England Journal of Medicine
PTSD and Ketamine - Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder Proof-of-Concept
Serotonin reuptake inhibitors (SRIs) are the only medications approved by the Food and Drug Administration for the treatment of... - Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder
Accumulating evidencesuggeststhat N-methyl-D-aspartatereceptor(NMDAR)antagonists(e.g.keta- mine) mayexertrapidantidepressanteffectsinMDDpatients. - The American Journal of Psychiatry
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression. - The American Journal of Psychiatry
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial. - The Lancet
Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight. - The Use of Ketamine in Neuropathic Pain
Hyperactivity of N-methyl-D-aspartate (NMDA) receptors may be one of the factors in the genesis of neuropathic pain (NP). - Ther Adv Psychopharmacol
Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy.
